Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jacobs

Showing results (801-810 of 3,722) with videos related to

Pageof 373
Sort By:
Clinics in Laboratory Medicine|June 5, 2004
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patternsThomas M File, Michael S Benninger, Michael R Jacobs
Journal of Clinical Microbiology|November 18, 1998
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologiesC L Clark, M R Jacobs, P C Appelbaum
Journal of Bacteriology|April 1, 1997
Cloning of the dapB gene, encoding dihydrodipicolinate reductase, from Mycobacterium tuberculosisM S Pavelka, T R Weisbrod, W R Jacobs
Antimicrobial Agents and Chemotherapy|February 1, 1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciM A Visalli, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|February 1, 1996
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazoleM R Jacobs, S K Spangler, P C Appelbaum
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1983
Nonsurgical management of a large recurrent glomus jugulare tumorS A Burres, H I Wilner, J R Jacobs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycinS K Spangler, M R Jacobs, P C Appelbaum
The Journal of Urology|October 12, 2000
Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia?J N Krieger, R R Jacobs, S O Ross
Pageof 373

Showing results (801-810 of 3,722) with videos related to

Sort By:
Pageof 373
Clinics in Laboratory Medicine|June 5, 2004
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patternsThomas M File, Michael S Benninger, Michael R Jacobs
Journal of Clinical Microbiology|November 18, 1998
Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologiesC L Clark, M R Jacobs, P C Appelbaum
Journal of Bacteriology|April 1, 1997
Cloning of the dapB gene, encoding dihydrodipicolinate reductase, from Mycobacterium tuberculosisM S Pavelka, T R Weisbrod, W R Jacobs
Antimicrobial Agents and Chemotherapy|February 1, 1996
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococciM A Visalli, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|February 1, 1996
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1990
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazoleM R Jacobs, S K Spangler, P C Appelbaum
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 1983
Nonsurgical management of a large recurrent glomus jugulare tumorS A Burres, H I Wilner, J R Jacobs
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1993
Comparative activity of the new fluoroquinolone Bay y3118 against 177 penicillin susceptible and resistant pneumococciS K Spangler, M R Jacobs, P C Appelbaum
Antimicrobial Agents and Chemotherapy|April 1, 1994
Susceptibilities of 177 penicillin-susceptible and -resistant pneumococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycinS K Spangler, M R Jacobs, P C Appelbaum
The Journal of Urology|October 12, 2000
Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia?J N Krieger, R R Jacobs, S O Ross
Pageof 373